EU, AstraZeneca end litigation, reach agreement on vaccine supply

We will continue helping the rest of the world, Health Commissioner Kyriakides says

Photo: EPA Commissioner for Health and Food Safety Stella Kyriakides

The EU and AstraZeneca reached on Friday an agreement which will secure the delivery of the remaining Covid-19 vaccine doses to Member States under the terms of the Advance Purchase Agreement concluded on 27 August 2020 with AstraZeneca, EC Press service reported. The agreement will also end the pending litigation before the Brussels Court."Today's settlement agreement guarantees the delivery of the remaining 200 million Covid-19 vaccine doses by AstraZeneca to the EU,” Commissioner for Health and Food Safety Stella Kyriakides said.

She pointed out that as the strongest supporter of global vaccine cooperation and solidarity, the EU will continue helping the rest of the world. “Our aim is to share at least 200 million doses of vaccines through COVAX with low and middle-income countries until the end of this year," Kyriakides added.

The settlement agreement provides for the firm commitment by AstraZeneca to deliver, in addition to the around 100 million doses delivered until end of Q2, 135 million doses by the end of 2021 (60 million doses by the end of Q3 and 75 million doses by the end of Q4) and the remaining doses (65 million) by the end of March 2022.This will bring the total number of doses delivered to 300 million doses as agreed under the contract.

Member States will be provided with regular delivery schedules and capped rebates will apply in the event of any delayed doses.

In view of the current and new escape SARS-CoV-2 variants, the Commission and the Member States are negotiating with companies already in the EU vaccine portfolio new agreements that would allow to purchase rapidly adapted vaccines in sufficient quantities to reinforce and prolong immunity.

In order to purchase the new vaccines, Member States are allowed to use the REACT-EU package, one of the largest programmes under the new instrument Next Generation EU that continues and extends the crisis response and crisis repair measures.

More on this subject: Coronavirus

Similar articles